Actively Recruiting
Per-oral Endoscopic Myotomy With Fundoplication for Achalasia - an International Multicenter Randomized Controlled Trial
Led by Chinese University of Hong Kong · Updated on 2024-12-03
81
Participants Needed
7
Research Sites
52 weeks
Total Duration
On this page
Sponsors
C
Chinese University of Hong Kong
Lead Sponsor
D
Deenanath Mangeshkar Hospital and Research Centre
Collaborating Sponsor
AI-Summary
What this Trial Is About
Achalasia is a common esophageal disorder characterized by failure of the lower esophageal sphincter to relax and absence of esophageal peristalsis, causing symptoms like difficulty swallowing, chest pain, and regurgitation. Researchers are investigating per-oral endoscopic myotomy with fundoplication (POEM-F) compared to conventional POEM as treatments for achalasia. This international multicenter randomized controlled trial aims to evaluate if POEM-F reduces the rate of gastroesophageal reflux disease (GERD) after treatment, a common complication seen in up to 50-60% of patients undergoing POEM. The study randomly assigns adult patients with manometry-confirmed achalasia to one of two groups: POEM-F or conventional POEM. In POEM-F, after the myotomy, an endoscopic fundoplication is performed mimicking surgical partial fundoplication to reduce GERD risk. Conventional POEM involves an anterior myotomy without fundoplication. Procedures are carried out by experts under general anesthesia. POEM-F includes additional steps such as creating a serosal incision and anchoring the gastric fundus to the esophagogastric junction using clips and an endoloop. Participants will be followed for one year to assess the rate of post-procedure GERD as the primary outcome. Additional assessments include procedure success, adverse events, endoscopic and manometry findings, and symptom questionnaires. The study involves baseline and follow-up evaluations including endoscopies and symptom scores. The goal is to provide evidence on the safety and effectiveness of POEM-F in reducing GERD and improving treatment outcomes for achalasia.
CONDITIONS
Brief Title
POEM-F for Achalasia International Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 65 years with symptomatic achalasia type I or II
- Able to understand and comply with study requirements, including filling out symptom questionnaires and signing informed consent
- Patients who are treatment naive or have failed prior balloon or pneumatic dilation for achalasia
You will not qualify if you...
- Unable or unwilling to provide consent
- Previous esophageal or gastric surgery
- Prior achalasia treatments such as Heller myotomy or POEM
- Sigmoid achalasia or significant esophageal dilation greater than 6 cm
- Damaged mucosa in the distal esophagus such as ulcers or scars
- Large hiatal hernias (axial length > 2 cm and Hill grade >2)
- Significant heart or lung problems limiting general anesthesia (ASA grade III or above)
- Obesity with body mass index 30 or higher
- Pregnant, planning pregnancy, or breastfeeding
- Uncorrectable blood clotting problems (INR > 1.5 or platelet count < 50000/µl)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants undergo either the POEM-F procedure, which combines per-oral endoscopic myotomy with fundoplication to help reduce post-procedure acid reflux, or the conventional POEM procedure without fundoplication. Both procedures are performed under general anesthesia by expert endoscopists.
1 procedure visit (in-person)
Duration - 1 year
Participants are monitored for clinical success, adverse events, and gastroesophageal reflux disease (GERD) symptoms through questionnaires and endoscopic evaluations over 1 year after the procedure.
Visits at 1 month, 3 months, 6 months, and 1 year post-procedure
Trial Site Locations
Total: 7 locations
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287
Not Yet Recruiting
2
Nanfang Hospital, Southern Medical University
Guangzhou, China
Not Yet Recruiting
3
The Chinese University of Hong Kong
Hong Kong, Hong Kong
Actively Recruiting
4
Post Graduate Institute of Medical Education and Research
Chandigarh, India
Not Yet Recruiting
5
Asian Institute of Gastroenterology
Hyderabad, India
Not Yet Recruiting
6
Baldota Institute of Digestive Sciences
Mumbai, India
Not Yet Recruiting
7
Deenanath Mangeshkar Hospital & Research Center
Pune, India
Not Yet Recruiting
Research Team
H
Hon Chi Yip, FRCSEd
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here